PIN1 and cancer: Dubiella et al. [135] showed that a Pin1 inhibitor Sulfopin reduced tumor progression and conferred survival benefits in animal models, while Liu et al. [136] developed a delivery system of a Pin1 inhibitor AG177724 targeting cancer-associated fibroblasts and observed the inhibition of tumor growth in mice.